04:27 PM EST, 01/30/2025 (MT Newswires) -- ResMed ( RMD ) reported fiscal Q2 non-GAAP earnings late Thursday of $2.43 per diluted share, up from $1.88 a year ago.

Analysts polled by FactSet expected $2.32.

Net revenue for the quarter ended Dec. 31 was $1.28 billion compared with $1.16 billion a year ago.

Analysts surveyed by FactSet expected $1.27 billion.

The medical device also declared a quarterly cash dividend of $0.53 per share, unchanged from the prior quarter and payable March 20 to shareholders of record on Feb. 13.